Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Apr 2026, May 2026, Jun 2026 and Jul 2026.
- Largest single sale: $1.5M (21,306 shares) of Spyre Therapeutics, Inc. on May 1, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | Chief Medical Officer | Oct 1, 2024 | Jul 2, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 1, 2026, Spyre Therapeutics, Inc.: sold 8,334 shares for $731K, under a disclosed plan; 8,334 shares acquired by exercising options. 1 filing: 1
- Jun 3, 2026, Spyre Therapeutics, Inc.: sold 8,333 shares for $625K, under a disclosed plan; 8,333 shares acquired by exercising options. 1 filing: 1
- May 1, 2026, Spyre Therapeutics, Inc.: sold 78,333 shares for $5.6M, under a disclosed plan; 78,333 shares acquired by exercising options. 1 filing: 1
- Apr 1, 2026, Spyre Therapeutics, Inc.: sold 7,958 shares for $398K, under a disclosed plan; 7,958 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.